C151 - Lewy Body Dementias
| Event Time: | Tuesday May 7, 2019 3:30 pm to 5:30 pm |
| Topic(s): | Aging, Dementia, Cognitive, and Behavioral Neurology, Foundations in Clinical Neurology for APPs |
| Director(s): | Karen Marder MD, MPH, FAAN |
| Description: | Dementia with Lewy Bodies (DLB) and Parkinson's Disease Dementia (PDD), collectively known as Lewy Body Dementias (LBD) are common but difficult to diagnose. Management of concomitant cognitive, motor, behavioral, and autonomic symptoms can be challenging. Cognitive impairment is now recognized as a seminal, often early feature in atypical parkinsonian disorders such as progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multisystem atrophy (MSA). Comprehensive genetic testing, not yet widely available to the clinician, may identify symptomatic and premanifest individuals who may ultimately benefit from specific targeted treatments. Faculty will use a case-based approach to introduce the clinical features of these disorders and will provide up-to-date recommendations on diagnosis, including interpretion of imaging and genetic testing. Faculty will provide an update on the latest pharmacological and non-pharmacological strategies. |
| Completion Message: | Participants should be able to apply up-to-date clinical criteria and diagnostic tools to diagnose Lewy body dementias and other parkinsonian dementias, understand the value and potential limitations of genetic testing for these disorders, and choose pharmacological and non-pharmacological strategies to treat cognitive, motor, behavioral, and autonomic symptomatology associated with these disorders. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge, Practice-Based Learning and Improvement |
| Start/End Time | Title | Faculty |
|---|---|---|
| 3:30 PM - 4:00 PM | Lewy Body Dementias (DLB and PDD): New Strategies for Diagnosis and Management | Jennifer G. Goldman MD, MS, FAAN |
| 4:00 PM - 4:10 PM | Questions and Answers | Faculty |
| 4:10 PM - 4:40 PM | Other Parkinsonian Dementias (PSP,CBS, MSA): Advances in Diagnosis and Management | Irene Litvan MD, FAAN |
| 4:40 PM - 4:50 PM | Questions and Answers | Faculty |
| 4:50 PM - 5:20 PM | Genetic Testing for Parkinsonian Dementias: Who, What, Why, and When? | Martha A. Nance MD |
| 5:20 PM - 5:30 PM | Questions and Answers | Faculty |
| Speaker | Disclosure |
|---|---|
| Jennifer G. Goldman, MD, MS, FAAN | Dr. Goldman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acadia, Aptinyx, Sunovion, and Worldwide Med. Dr. Goldman has received research support from Michael J. Fox Foundation, Parkinson's Foundation, NIH, and CHDI. |
| Irene Litvan, MD, FAAN | Dr. Litvan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AbbVie, Inc.; Toyama Pharmaceuticals ; Biotie/Parkinson Study Group Medical Advisory Board. Dr. Litvan has received personal compensation in an editorial capacity as Chief Editor of Frontiers in Neurology. Dr. Litvan has received research support from AVID Pharmaceuticals, C2N Diagnostics/Abbvie, Inc.; and Bristol-Myers Squibb/Biogen. . |
| Martha A. Nance, MD | Dr. Nance has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche. Dr. Nance has received research support from Teva Pharmaceuticals and Dong-A ST Co, Ltd. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
| 9:15 AM-11:30 AM |
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 11:45 AM-12:45 AM |
|
Friday Grand Finale: Neuroimaging
|
| 1:00 PM-3:00 PM |
|
C252 -
Update in Aging and Dementia
Gil Rabinovici MD |
| 3:30 PM-4:30 PM |
|
C255 -
Education Blitz: Normal Pressure Hydrocephalus
Neill Graff-Radford MD, FAAN |